Zhang Chengcheng

Dr. Zhang Chengcheng


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
FXFusheng Xu
Fusheng Xu
RCRuimin Chen
Ruimin Chen
ZCZhang Chengcheng
Zhang Chengcheng
HWHao Wang
Hao Wang
ZDZhijie Ding
Zhijie Ding
QZQixiao Zhai
Qixiao Zhai
Cholecystectomy (CCE) is a standard clinical treatment for conditions like gallstones and cholecystitis. However, its link to post-CCE syndrome, colorectal cancer, and nonalcoholic fatty liver disease has raised concerns. Additionally, studies have demonstrated the disruptive effects of CCE on gut microbiota homeostasis and bile acid (BA) metabolism. Considering the role of gut microbiota in regulating host metabolic and immune pathways, the use of dietary and probiotic intervention strategies to maintain a stable gut ecosystem after CCE could potentially reduce associated disease risks. Inter-study variations have made it challenging to identify consistent gut microbiota patterns after CCE, a prerequisite for targeted interventions. In this study, we first meta-analyzed 218 raw 16S rRNA gene sequencing datasets to determine consistent patterns of structural and functional changes in the gut microbiota after CCE. Our results revealed significant alterations in the gut microbiota’s structure and function due to CCE. Furthermore, we identified characteristic gut microbiota changes associated with CCE by constructing a random model classifier. In the validation cohort, this classifier achieved an area under the receiver operating characteristic curve (AUC) of 0.713 and 0.683 when distinguishing between the microbiota of the CCE and healthy groups at the family and genus levels, respectively. Further, fecal metabolomics analysis demonstrated that CCE also substantially modified the metabolic profile, including decreased fecal short-chain fatty acid levels and disrupted BA metabolism. Importantly, dietary patterns, particularly excessive fat and total energy intake, influenced gut microbiota and metabolic profile changes post-CCE. These dietary habits were associated with further enrichment of the microbiota related to BA metabolism and increased levels of intestinal inflammation after CCE. In conclusion, our study identified specific alterations in gut microbiota homeostasis and metabolic profiles associated with CCE. It also revealed a potential link between dietary patterns and gut microbiota changes following CCE. Our study provides a theoretical basis for modulating gut microbiota homeostasis after CCE using long-term dietary strategies and probiotic interventions.

29 March 2024 in Food Research International
Verified
Journal Article
Closed access
YGYuhang Gao
Yuhang Gao
LYLeilei Yu
Leilei Yu
ZYZi Ye
Zi Ye
CZChuan Zhang
Chuan Zhang
YGYuhong Gong
Yuhong Gong
FTFengwei Tian
Fengwei Tian

28 April 2023 in Polymers
Verified
Journal Article
Open access
PDF file
RZRuohan Zhao
Ruohan Zhao
CZChuan Zhang
Chuan Zhang
LYLeilei Yu
Leilei Yu
ZCZhang Chengcheng
Zhang Chengcheng
JZJianxin Zhao
Jianxin Zhao
FTFengwei Tian
Fengwei Tian
Hyaluronan (HA) has various biological functions and is used extensively as a dietary supplement. Previous studies have shown that the probiotic effects of polysaccharides are closely associated with their molecular properties. The intestinal microbiota has been demonstrated to degrade HA; however, the regulatory effects of different molecular weights (MW) of HA on gut microbiota and metabolites are unknown. In the present study, we performed in vitro fermentation of human-derived feces for three MWs of HA (HA1, 32.3 kDa; HA2, 411 kDa; and HA3, 1510 kDa) to investigate the differences in the fermentation properties of HA with different MWs. We found that gut microbiota can utilize all HAs and, consequently, produce large amounts of short-chain fatty acids (SCFAs). In addition, we showed that all three HA MWs promoted the growth of Bacteroides, Parabacteroides, and Faecalibacterium, with HA1 being more effective at promoting the growth of Bacteroides. HAs have various regulatory effects on the structure and metabolites of the gut microbiota. Spearman’s correlation analysis revealed that alterations in gut microbiota and their metabolites were significantly correlated with changes in metabolic markers. For instance, HA1 enriched α-eleostearic acid and DL-3-aminoisobutyric acid by regulating the abundance of Bacteroides, and HA3 enriched Thymidin by regulating Faecalibacterium. Collectively, the fermentation properties of HA vary across MW, and our results provide insights into the potential association between the MW of HA and its fermentation characteristics by the gut microbiota. These findings provide insights into the influence of the gut microbiota and HAs on the health of the host.

24 January 2026 in Foods
Verified
Journal Article
Open access
PDF file
DDDuan Duan
Duan Duan
Qijie GuanQijie Guan
Qijie Guan
YRYilin Ren
Yilin Ren
JSJin-Song Shi
Jin-Song Shi
ZXZheng-Hong Xu
Zheng-Hong Xu
YGYan Geng
Yan Geng
Cereal vinegar sediment (CVS), a byproduct of traditional vinegar fermentation, has been regarded as a health-promoting product. However, its role in genetically induced hyperlipidemia remains unclear. This study systematically evaluated the effects of Dade-CVS (DD-CVS) and Hengshun-CVS (HS-CVS) on apolipoprotein-E-deficient (Apoe−/−) mice. Both CVS varieties significantly improve certain serological parameters of Apoe−/− mice, although the overall impact on serum indicators remains limited. Nevertheless, 16S rRNA sequencing revealed that CVS treatment reshaped gut microbial communities to a notable extent. Compared with the Apoe−/− mice, the DD-CVS treatment significantly increased the relative abundance of Dubosiella while reducing the genus Desulfovibrio, whereas the HS-CVS treatment inhibited the growth of Bifidobacterium and Akkermansia. The pathways predicted in the KO-DD group included vitamin, amino acid, and energy metabolism, while HS-CVS treatment was associated with bile acid biosynthesis and energy pathways. Metabolomic analysis showed that several key metabolites, including N1-acetylspermidine, succinic acid, and 25-hydroxycholesterol, were significantly altered following CVS supplementation. Correlation analysis revealed significant associations between serum indicators and these metabolites. Alistipes, Enterorhabdus, and Romboutsia were also correlated with serum indicators. Overall, these findings indicate that CVS primarily modulated the gut microbiota–metabolite axis and partial lipid modulation in hyperlipidemic mice. The study provides a reference for studies on the beneficial functions of CVS in hyperlipidemia.

15 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
DDDuan Duan
Duan Duan
YRYilin Ren
Yilin Ren
Qijie GuanQijie Guan
Qijie Guan
JSJin-Song Shi
Jin-Song Shi
ZXZheng-Hong Xu
Zheng-Hong Xu
YGYan Geng
Yan Geng
Background: Cereal vinegar sediment (CVS), a byproduct formed during traditional grain vinegar storage, possesses lipid-lowering, glucose-lowering, and antioxidant properties. However, its effects on gut microbial and metabolic responses to short-term high-fat diet [HFD] exposure remain unclear. This study aimed to characterize the compositional profiles of Dade CVS (DD-CVS) and Hengshun CVS (HS-CVS) and investigate their effects on host metabolism and gut microbiota in mice with short-term HFD exposure. Methodology: The physicochemical properties of CVSs were evaluated, and their chemical compositions were characterized via untargeted metabolomics. Mice were fed a short-term HFD and administered DD-CVS or HS-CVS. Gut microbiota, cecal metabolites, and serum metabolites were analyzed using 16S rRNA gene sequencing, metabolomics, and integrative multi-omics analysis. Results: Both CVSs were rich in amino acids, their derivatives, and polyphenolic compounds. CVS treatments attenuated body-weight gain and reshaped the gut microbiota composition of mice, including changes in the relative abundance of Allobaculum, Akkermansia, and Lachnospiraceae_Clostridium. Differentially, DD-CVS enriched Blautia and Ruminococcus, whereas HS-CVS promoted Bacillus. The results of gut microbial metabolic profiles showed that DD-CVS treatment regulated amino acid metabolism, while HS-CVS treatment influenced bile acid and arachidonic acid metabolism. Furthermore, serum metabolomics revealed that CVSs modulated systemic metabolic profiles and enriched CVS-associated compounds, such as α-linolenic acid. The candidate microbiota-sensitive metabolites, including lithocholic acid and 9(S)-HPODE, showed significant correlations with specific microbial taxa. Conclusion: DD-CVS and HS-CVS induced distinct gut microbial and metabolic responses during short-term HFD exposure, supporting further evaluation of CVS as a potential functional food.